Literature DB >> 30485434

Interaction between genetic ancestry and common breast cancer susceptibility variants in Colombian women.

Diana Torres1,2, Justo Lorenzo Bermejo3, Karen Garcia Mesa1,3, Michael Gilbert1, Ignacio Briceño2,4, Svenja Pohl-Zeidler1, Rosa González Silos3, Felix Boekstegers3, Christoph Plass5, Ute Hamann1.   

Abstract

Latino women show lower incidences of breast cancer (BC) than non-Hispanic whites. Large-scale genetic association studies have identified variants robustly associated with BC risk in European women. We examine here the relevance of these variants to Colombian BC and possible interactions with genetic ancestry. Native American, European and African proportions were estimated for 1022 Colombian BC cases and 1023 controls. Logistic regression was applied to assess the association between 78 variants and BC risk and interactions between the variants and ancestry proportions. We constructed a multifactorial risk score combining established BC risk factors, associated risk variants and individual ancestry proportions. Each 1% increase in the Native American proportion translated into a 2.2% lower BC risk (95% CI: 1.4-2.9). Thirteen variants were associated with BC in Colombian women, with allele frequencies and risk effects partially different from European women. Ancestry proportions moderated the risk effects of two variants. The ability of Native American proportions to separate Colombian cases and controls (area-under-the-curve (AUC) = 0.61) was similar to the discriminative ability of family history of BC in first-degree female relatives (AUC = 0.58) or the combined effect of all 13 associated risk variants (AUC = 0.57). Our findings demonstrate ample potential for individualized BC prevention in Hispanic women taking advantage of individual Native American proportions, information on established susceptibility factors and recently identified common risk variants.
© 2018 UICC.

Entities:  

Keywords:  Colombia; Hispanics; breast cancer; genetic ancestry; risk factors

Mesh:

Year:  2019        PMID: 30485434     DOI: 10.1002/ijc.32023

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

Review 1.  Genetic Epidemiology of Breast Cancer in Latin America.

Authors:  Valentina A Zavala; Silvia J Serrano-Gomez; Julie Dutil; Laura Fejerman
Journal:  Genes (Basel)       Date:  2019-02-18       Impact factor: 4.096

2.  Genetic Variability in the microRNA Binding Sites of BMPR1B, TGFBR1, IQGAP1, KRAS, SETD8 and RYR3 and Risk of Breast Cancer in Colombian Women.

Authors:  Karen Garcia Mesa; Justo Lorenzo Bermejo; Diana Torres; Michael Gilbert; Christoph Plass; Ute Hamann
Journal:  Onco Targets Ther       Date:  2020-11-30       Impact factor: 4.147

3.  Natural Compounds or Their Derivatives against Breast Cancer: A Computational Study.

Authors:  Rajib Hossain; Pranta Ray; Chandan Sarkar; Md Shahazul Islam; Rasel Ahmed Khan; Abul Bashar Ripon Khalipha; Muhammad Torequl Islam; William C Cho; Miquel Martorell; Javad Sharifi-Rad; Monica Butnariu; Almagul Umbetova; Daniela Calina
Journal:  Biomed Res Int       Date:  2022-07-05       Impact factor: 3.246

Review 4.  Therapeutic Attributes of Endocannabinoid System against Neuro-Inflammatory Autoimmune Disorders.

Authors:  Ishtiaq Ahmed; Saif Ur Rehman; Shiva Shahmohamadnejad; Muhammad Anjum Zia; Muhammad Ahmad; Muhammad Muzammal Saeed; Zain Akram; Hafiz M N Iqbal; Qingyou Liu
Journal:  Molecules       Date:  2021-06-03       Impact factor: 4.411

5.  Haplotypes of single cancer driver genes and their local ancestry in a highly admixed long-lived population of Northeast Brazil.

Authors:  Steffany Larissa Galdino Galisa; Priscila Lima Jacob; Allysson Allan de Farias; Renan Barbosa Lemes; Leandro Ucela Alves; Júlia Cristina Leite Nóbrega; Mayana Zatz; Silvana Santos; Mathias Weller
Journal:  Genet Mol Biol       Date:  2022-02-02       Impact factor: 1.771

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.